Home > Insider Trading > Filing (0001237899-15-000021)

Filing Details

Accession Number:: 0001237899-15-000021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-25 16:02:38
Reporting Period:: 2015-02-23

Filing Date:: 2015-02-25
Accepted Time:: 2015-02-25 16:02:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1487767	S Michael Aberman	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Strategy Investor Relation	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-23	7,500	$30.63	26,100	No	4	M	Direct
Common Stock	Disposition	2015-02-23	536	$427.94	25,564	No	4	F	Direct
Common Stock	Disposition	2015-02-23	3,590	$427.94	21,974	No	4	F	Direct
Common Stock	Disposition	2015-02-24	600	$416.31	21,374	No	4	S	Direct
Common Stock	Disposition	2015-02-24	471	$417.23	20,903	No	4	S	Direct
Common Stock	Disposition	2015-02-24	800	$418.33	20,103	No	4	S	Direct
Common Stock	Disposition	2015-02-24	1,103	$419.52	19,000	No	4	S	Direct
Common Stock	Disposition	2015-02-24	400	$420.64	18,600	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-02-23	7,500	$0.00	7,500	$30.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500		2020-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	407	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 600 shares of Company stock on February 24, 2015 at prices ranging from $416.01 to $416.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2015 at each separate price.
Represents volume-weighted average price of sales of 471 shares of Company stock on February 24, 2015 at prices ranging from $417.08 to $417.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2015 at each separate price.
Represents volume-weighted average price of sales of 800 shares of Company stock on February 24, 2015 at prices ranging from $418.07 to $418.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2015 at each separate price.
Represents volume-weighted average price of sales of 1,103 shares of Company stock on February 24, 2015 at prices ranging from $419.00 to $419.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2015 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on February 24, 2015 at prices ranging from $420.30 to $420.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2015 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.